## **Core Concept**
Sitagliptin is a medication used in the management of type 2 diabetes mellitus. It belongs to the class of drugs known as **DPP-4 inhibitors** (Dipeptidyl peptidase-4 inhibitors), which work by enhancing the activity of incretin hormones. Incretin hormones, such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), play a crucial role in regulating blood glucose levels.

## **Why the Correct Answer is Right**
The correct mechanism of action of sitagliptin involves the inhibition of the DPP-4 enzyme. This enzyme breaks down incretin hormones. By inhibiting DPP-4, sitagliptin increases the levels of incretin hormones, which in turn stimulates the release of **insulin** when glucose levels are elevated and decreases the release of **glucagon** by the liver. This action leads to a decrease in glucose levels in the blood, making it an effective treatment for type 2 diabetes.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Not provided, hence cannot be evaluated.
- **Option B:** Not provided, hence cannot be evaluated.
- **Option C:** Not provided, hence cannot be evaluated.
- **Option D:** Not provided, hence cannot be evaluated.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl about sitagliptin is that it has a **favorable side effect profile** and is generally well-tolerated. Unlike some other diabetes medications, sitagliptin does not typically cause significant weight gain or hypoglycemia when used as monotherapy. However, it's worth noting that sitagliptin can be used in combination with other diabetes medications.

## **Correct Answer:** D.